[The silent pandemic - antimicrobial resistance]

Laeknabladid. 2022 Mar;108(3):119. doi: 10.17992/lbl.2022.03.678.

[Article in Icelandic]

Author

Karl G Kristinsson¹

Affiliation

¹ MD, PhD, FRCPath Department of Clinical Microbiology, Landspitali - The National University Hospital of Iceland, Faculty of Medicine, University of Iceland.

PMID: 35230255
DOI: 10.17992/lbl.2022.03.678

No abstract available

Publication types

Editorial

MeSH terms

Anti-Bacterial Agents* / adverse effects
COVID-19*
Drug Resistance, Bacterial
Humans
Pandemics
SARS-CoV-2

Substances

Anti-Bacterial Agents